Novo Nordisk's pricing approaches within the U.S. have drawn sharp criticism from lawmakers like Senator Sanders, who may have accused the company of value gouging, pointing out the stark contrast in between U.S. costs and those in Europe and copyright. Even so, It is really critical to s